Provided by Tiger Fintech (Singapore) Pte. Ltd.

TNF Pharmaceuticals, Inc.

0.3680
+0.02106.05%
Post-market: 0.36990.0019+0.52%19:46 EDT
Volume:139.63K
Turnover:48.79K
Market Cap:1.01M
PE:-0.03
High:0.3680
Open:0.3443
Low:0.3443
Close:0.3470
Loading ...

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

Business Wire
·
05 Mar

Tnf Pharmaceuticals Initiates Phase 2B Clinical Trial of First Oral Tnf-Alpha Inhibitor

THOMSON REUTERS
·
25 Feb

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

Business Wire
·
25 Feb

TNF Pharmaceuticals to study TNF-alpha in patients taking GLP-1s

TIPRANKS
·
29 Jan

Tnf Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During Glp-1 Weight Loss Treatment

THOMSON REUTERS
·
29 Jan

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

Business Wire
·
29 Jan

TNF Pharmaceuticals isomyosamine trial demonstrates safety

TIPRANKS
·
15 Jan

Tnf Pharmaceuticals Inc - to Begin Phase 2B Study in Sarcopenia

THOMSON REUTERS
·
15 Jan

Tnf Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

THOMSON REUTERS
·
15 Jan

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Business Wire
·
15 Jan

TNF Pharmaceuticals, Renova Health announce trial to explore isomyosamine

TIPRANKS
·
19 Dec 2024

BRIEF-Tnf Pharmaceuticals Announces Trial To Explore Effects Of Lead Candidate In Sarcopenia/Frailty Induced By Glp-1 Weight Loss Drugs

Reuters
·
19 Dec 2024

Tnf Pharmaceuticals Inc - Enters Collaborative Agreement With Renova Health

THOMSON REUTERS
·
19 Dec 2024

Tnf Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by Glp-1 Weight Loss Drugs

THOMSON REUTERS
·
19 Dec 2024

Tnf: Fully Funded Study to Evaluate Wegovy and Ozempic Patients at Risk for Increased Inflammation Associated With Sarcopenic Muscle Deterioration

THOMSON REUTERS
·
19 Dec 2024

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Business Wire
·
19 Dec 2024